Dengue
- PMID: 30696575
- DOI: 10.1016/S0140-6736(18)32560-1
Dengue
Abstract
Mortality from severe dengue is low, but the economic and resource burden on health services remains substantial in endemic settings. Unfortunately, progress towards development of effective therapeutics has been slow, despite notable advances in the understanding of disease pathogenesis and considerable investment in antiviral drug discovery. For decades antibody-dependent enhancement has been the prevalent model to explain dengue pathogenesis, but it was only recently demonstrated in vivo and in clinical studies. At present, the current mainstay of management for most symptomatic dengue patients remains careful observation and prompt but judicious use of intravenous hydration therapy for those with substantial vascular leakage. Various new promising technologies for diagnosis of dengue are currently in the pipeline. New sample-in, answer-out nucleic acid amplification technologies for point-of-care use are being developed to improve performance over current technologies, with the potential to test for multiple pathogens using a single specimen. The search for biomarkers that reliably predict development of severe dengue among symptomatic individuals is also a major focus of current research efforts. The first dengue vaccine was licensed in 2015 but its performance depends on serostatus. There is an urgent need to identify correlates of both vaccine protection and disease enhancement. A crucial assessment of vector control tools should guide a research agenda for determining the most effective interventions, and how to best combine state-of-the-art vector control with vaccination.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
The Potential Impact of Vaccination on the Dynamics of Dengue Infections.Bull Math Biol. 2015 Dec;77(12):2212-30. doi: 10.1007/s11538-015-0120-6. Epub 2015 Nov 19. Bull Math Biol. 2015. PMID: 26585748
-
Dengue human infection models to advance dengue vaccine development.Vaccine. 2015 Dec 10;33(50):7075-82. doi: 10.1016/j.vaccine.2015.09.052. Epub 2015 Sep 28. Vaccine. 2015. PMID: 26424605
-
A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.Theor Biol Med Model. 2018 Sep 3;15(1):13. doi: 10.1186/s12976-018-0085-x. Theor Biol Med Model. 2018. PMID: 30173664 Free PMC article.
-
Challenges in reducing dengue burden; diagnostics, control measures and vaccines.Expert Rev Vaccines. 2013 Sep;12(9):995-1010. doi: 10.1586/14760584.2013.824712. Expert Rev Vaccines. 2013. PMID: 24053394 Review.
-
Understanding dengue pathogenesis: implications for vaccine design.Bull World Health Organ. 2005 Apr;83(4):308-14. Epub 2005 Apr 25. Bull World Health Organ. 2005. PMID: 15868023 Free PMC article. Review.
Cited by
-
A Thioester-Containing Protein Controls Dengue Virus Infection in Aedes aegypti Through Modulating Immune Response.Front Immunol. 2021 May 13;12:670122. doi: 10.3389/fimmu.2021.670122. eCollection 2021. Front Immunol. 2021. PMID: 34054842 Free PMC article.
-
Clinical and prognostic relevance of sST2 in adults with dengue-associated cardiac impairment and severe dengue.PLoS Negl Trop Dis. 2022 Oct 13;16(10):e0010864. doi: 10.1371/journal.pntd.0010864. eCollection 2022 Oct. PLoS Negl Trop Dis. 2022. PMID: 36228040 Free PMC article.
-
Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine.PLoS Negl Trop Dis. 2020 Sep 21;14(9):e0008676. doi: 10.1371/journal.pntd.0008676. eCollection 2020 Sep. PLoS Negl Trop Dis. 2020. PMID: 32956362 Free PMC article.
-
Dengue: A Minireview.Viruses. 2020 Jul 30;12(8):829. doi: 10.3390/v12080829. Viruses. 2020. PMID: 32751561 Free PMC article. Review.
-
Demographic characteristics, clinical symptoms, biochemical markers and probability of occurrence of severe dengue: A multicenter hospital-based study in Bangladesh.PLoS Negl Trop Dis. 2023 Mar 15;17(3):e0011161. doi: 10.1371/journal.pntd.0011161. eCollection 2023 Mar. PLoS Negl Trop Dis. 2023. PMID: 36921001 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical